松果体区胶质母细胞瘤的临床特征、治疗与生存结局
本研究回顾性分析新诊断松果体胶质母细胞瘤47例(含本院3例及文献44例),中位年龄46岁,90.9%术前梗阻性脑积水。中位总生存期10.0个月,活检和化疗为独立预后因素,放化疗联合生存获益更佳。
要点
- 松果体胶质母细胞瘤罕见,常伴梗阻性脑积水(90.9%)和软脑膜播散(55.3%)。
- 中位总生存期仅10.0个月,1年生存率42.6%。
- 活检和化疗是独立良好预后因素,放化疗联合优于其他方案。
核心结论
- 松果体胶质母细胞瘤预后差,中位总生存期10.0个月。
- 接受活检或化疗的患者总生存期更好,为独立预后因素。
- 放化疗联合较其他方案有更好的生存获益。
研究设计与样本
- 回顾性分析新诊断松果体胶质母细胞瘤患者,包括本院3例和文献报道44例,共47例。
- 采用Kaplan-Meier法进行生存分析,Cox回归分析确定预后因素。
主要发现
- 共47例患者(男28例,女19例),中位年龄46岁(范围5-74岁)。
- 44例(90.9%)术前存在梗阻性脑积水。
- 38例中21例(55.3%)存在远端软脑膜播散。
- 辅助治疗:放疗36例,化疗27例;中位总生存期10.0个月,6个月、1年、2年生存率分别为68.0%、42.6%、17.0%。
关键数值与推荐
- Cox回归显示活检(P=0.042)和化疗(P=0.029)与更好的总生存期相关,为独立预后因素。
- 进一步生存分析显示放化疗联合较其他方案有更好的生存获益。
临床怎么用
- 对于松果体胶质母细胞瘤,应重视活检以明确诊断。
- 化疗是独立预后因素,建议纳入综合治疗。
- 放化疗联合可能带来更优生存,可作为治疗选择参考。
局限性
- 回顾性研究,样本量小(47例),部分数据来自文献。
- 罕见病种,可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Given the rarity of patients with pineal glioblastoma (GBM), clinical characteristics, treatment, and prognostic factors are not well characterized. This study aimed to investigate these characteristics and identify the prognostic factors of overall survival (OS). METHODS: A retrospective analysis of newly diagnosed patients with pineal GBM, including our 3 cases and an additional 44 cases from published articles, was conducted. Survival analysis was performed by Kaplan-Meier analysis and Cox regression analysis was used to determine the prognostic factors. RESULTS: A total of 47 patients (28 males and 19 females) were enrolled, with a median age of 46 years (range, 5-74 years). Forty-four patients (90.9%) had preoperative obstructive hydrocephalus. Among 38 patients, 21 (55.3%) had distal leptomeningeal dissemination. Forty-five patients (95.7%) had resection/biopsy, 6 of whom had gross total resection, 22 had subtotal resection, 7 had partial resection, and 10 had biopsy. Adjuvant therapy included radiotherapy in 36 patients and chemotherapy in 27 patients. The median OS was 10.0 months. The 6-month, 1-year, and 2-year survival was 68.0%, 42.6%, and 17.0%, respectively. Cox regression analysis showed that patients receiving biopsy (P = 0.042) or chemotherapy (P = 0.029) had the better OS and these were regarded as independent prognostic factors. Further survival analysis showed that chemoradiotherapy had better survival benefit than other regimens. CONCLUSIONS: In this study, we summarized the characteristics of patients with pineal GBM and showed the correlation between clinical characteristics and prognosis. This study may give readers a deep understanding of these rare GBMs and provide some references for future management.
引用
- Niu X, Wang C, Zhou X, et al. Pineal Region Glioblastomas: Clinical Characteristics, Treatment, and Survival Outcome. World Neurosurg. 2020. PMID: 33186787. doi:10.1016/j.wneu.2020.11.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。